Genital Herpes-Pipeline Insights, 2014

 
 
Spread the Word
Listed Under

Tags:
* Genital Herpes
* Pipeline Drugs
* Reports
* Pipeline
* Clinical drugs

Industrys:
* Business
* Reports

Location:
* Dwarka - Delhi - India

Subject:
* Products

DWARKA, India - Aug. 29, 2014 - PRLog -- DelveInsight’s,“ Genital Herpes-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Genital Herpes. This report provides information on the therapeutic development based on the Genital Herpes dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope
- The report provides a snapshot of the global therapeutic landscape of Genital Herpes
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Genital Herpes pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Genital Herpes and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Genital Herpes
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Genital Herpes pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table of Contents
- Genital Herpes Overview
- Genital Herpes Pipeline Therapeutics
- Genital Herpes Therapeutics under Development by Companies
- Genital Herpes Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Genital Herpes Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Genital Herpes Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Genital Herpes Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Genital Herpes - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Genital Herpes - Discontinued Products
- Genital Herpes - Dormant Products
- Companies Involved in Therapeutics Development for Genital Herpes
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Genital Herpes, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Genital Herpes Assessment by Monotherapy Products
- Genital Herpes Assessment by Combination Products
- Genital Herpes Assessment by Route of Administration
- Genital Herpes Assessment by Stage and Route of Administration
- Genital Herpes Assessment by Molecule Type
- Genital Herpes Assessment by Stage and Molecule Type
- Genital Herpes Therapeutics - Discontinued Products
- Genital Herpes Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Genital Herpes, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Genital Herpes Assessment by Monotherapy Products
- Genital Herpes Assessment by Combination Products
- Genital Herpes Assessment by Route of Administration
- Genital Herpes Assessment by Stage and Route of Administration
- Genital Herpes Assessment by Molecule Type
- Genital Herpes Assessment by Stage and Molecule Type

Contact
Mridhu Verma
info@delveinsight.com
+91-11-4568 9769
End
Email:***@delveinsight.com Email Verified
Tags:Genital Herpes, Pipeline Drugs, Reports, Pipeline, Clinical drugs
Industry:Business, Reports
Location:Dwarka - Delhi - India
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DelveInsight News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share